PubRank

Ėksperimental'nai︠a︡ i klinicheskai︠a︡ gastroėnterologii︠a︡ = Experimental & clinical gastroenterology (Eksp Klin Gastroenterol)

Journal PubWeight™ 72.77‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 [Semax and some glyproline peptides accelerate the healing of acetic ulcers in rats]. 2003 0.97
2 [Dynamics of clinical symptoms, indices of quality of life, and the state of motor function of the esophagus and rectum in patients with functional dyspepsia and irritable bowel syndrome after Helicobacter pylori eradication]. 2003 0.83
3 [Association of Helicobacter pylori with chronic cholecystitis]. 2003 0.83
4 [Gastrointestinal giardiasis associated with Helicobacter pylori]. 2010 0.83
5 [Effect of the anesthesia method on the immune status of gerontological patients during abdominal operations]. 2004 0.83
6 [Cell adhesion molecules in evaluation of Crohn's disease therapy]. 2013 0.81
7 THINK PORPHYRIA: CASE REPORT AND REVIEW OF LITERATURE. 2015 0.81
8 [The results of endoscopic mucosal resection and submucosal layer endoscopic dissection in patients with superficial epithelial neoplasms of stomach and duodenum]. 2011 0.81
9 [Hemorrhoids]. 2002 0.81
10 [Realities and prospects for the use of cell technologies for the treatment of chronic diffuse liver diseases]. 2011 0.80
11 [Experimental study of the effect of the phytomixture made of leaves of Plantago major L. and Achillea millenfolium L. on the secretion activity of the stomach in dogs]. 2005 0.80
12 [Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy]. 2011 0.80
13 [Minimally invasive interventions in the treatment of patients with acute necrotizing pancreatitis]. 2014 0.79
14 [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics]. 2005 0.79
15 [Crystallo-optic structures of bile in chronic acalculous cholecystitis]. 2002 0.79
16 [Modern myths of clinical gastroenterology]. 2004 0.79
17 [Diseases associated with Helicobacter pylori and Candida spp.: clinical logic of combined studies]. 2005 0.79
18 [The level of serum cytokines in children infected with various strains of Helicobacter pylori]. 2010 0.79
19 [Probiotics in the treatment of functional intestinal diseases]. 2012 0.79
20 [Antiproliferative activity of diclofenac at tumor cell cultures]. 2012 0.79
21 [Effect of HP eradication on the development of gastroesophageal reflux disease: results of the prospective study]. 2011 0.79
22 [Endoscopic criteria for diagnosis of various macroscopic variants of non-Hodgkin's gastric lymphoma]. 2010 0.79
23 [Early gastric cancer and precancerous conditions diagnostics with confocal laser endomicroscopy]. 2014 0.79
24 [Pathogenesis of esophageal and gastric varicose veins formation in patients with liver cirrhosis]. 2011 0.79
25 [Pathogenetic importance of proinflammatory cytokines in the formation and progression of fibrosis in alcoholic hepatitis]. 2013 0.78
26 [Mesenchymal stromal cells transplantation in acute and chronic pancreatitis in rats]. 2011 0.78
27 [FAMILIAL CLUSTERS OF HEPATITIS DELTA IN ENDEMIC REGION (REPUBLIC TYVA)]. 2015 0.78
28 [The quality of life dynamics in patients with gastroesophageal reflux disease during rabeprazol therapy]. 2009 0.78
29 [Helicobacter pylori infection and state of antioxidant protection in patients with the unstable course of ischemic disease]. 2004 0.78
30 [Features of mucosal flora associated with relapse of ulcers and acute erosive-ulcer damage to the gastroduodenal zone during an unstable course of ischemic heart disease]. 2002 0.78
31 [Clinical assessment of the efficacy of early enteral nutrition with the help of "peptamen" nutriment in patients who underwent gastrectomy due to stomach cancer]. 2003 0.78
32 [Structure, biological properties of honey, pollen and royal jelly and their possible use in nutrition therapy]. 2009 0.78
33 [Prevention of antibiotic-associated diarrhea in children]. 2011 0.78
34 [Pancreas at metabolic syndrome]. 2010 0.78
35 [Endoscopic ultrasonography in the diagnosis of neuroendocrine tumors of the pancreas]. 2010 0.78
36 [Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)]. 2013 0.78
37 [Hepatic steatosis and fatty pancreas--2 targets of metabolic syndrom in children]. 2014 0.77
38 [Alterations of lymphocyte subsets and indicators of immune suppression in patients with acute pancreatitis]. 2014 0.77
39 [Syndrome of bacterial overgrowth in patients with the reduced stomach acid secretion: some aspects of the diagnosis]. 2014 0.77
40 [Overview of international recommendations on approaches a view of a physician and surgeon]. 2013 0.77
41 [Use of peg-intron in combined treatment of chronic liver disease caused by HIV infection]. 2003 0.77
42 [Chronic constipations in elderly people]. 2004 0.77
43 [Peculiarities of genotype distribution of interleukins (IL-1 and IL-10) in patients with peptic ulcer disease and their associations with persistence of Mycoplasma hyorhinis and Helicobacter pylori genotypes]. 2008 0.77
44 [New international classification of chronic pancreatitis (2007) M-ANNHEIM]. 2010 0.77
45 [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy]. 2009 0.77
46 [Reproductive disorders in women with celiac disease. Effect of the etiotropic therapy]. 2011 0.77
47 [Portal gastropathy: diagnosis, classification]. 2012 0.77
48 [Cost-effectiveness of tumor necrosis factor in Crohn's disease]. 2012 0.77
49 [Role of stress in the etiopathogenesis of duodenal ulcer in young patients]. 2002 0.77
50 [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease]. 2003 0.77
Next 50